Puma Biotechnology and Pierre Fabre’s Amendment of NERLYNX License Agreement

IN BRIEF: McDermott Will & Emery, advised on the matter.McDermott Will & Emery advised Pierre Fabre S.A. with a team including Anne-France Moreau (Life Science &…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Naoual Sadouqi

Author: Naoual Sadouqi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here